By bridging the gap between DTC and HCP silos and prioritizing medically validated “safe spaces,” brands can move beyond the vanity metrics of reach to secure the high-value trust that drives patient action and clinical validation.

Explore strategic ways to engage hard-to-reach patient populations by prioritizing humility, empathetic design, and flexible research methodologies over standard demographic data